Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial.
D000293:Adolescent; D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001545:Benserazide / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008064:Lipidoses / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology; D013577:Syndrome
D000978:Antiparkinson Agents; D004338:Drug Combinations; C005177:benserazide, levodopa drug combination; D007980:Levodopa; D001545:Benserazide; D000547:Amantadine